SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Upstream Processing

Oxford Genetics secures investment; expands UK facility and eyes US market

23-Aug-2017 - Oxford Genetics will expand its bioproduction services in the UK and target the US market through an office in Boston after receiving a £7.5m ($9.6m) investment.

Agilent 'outpacing the market' with double-digit biopharma growth

22-Aug-2017 - Agilent Technologies says it is benefitting from increased antibody and biosimilar R&D and manufacturing, reporting a double-digit growth for its third quarter.

Vendors optimistic for future despite slowdown in growth

18-Aug-2017 - Bioprocessing suppliers have recently expressed optimism in the sector despite a slowdown in growth, and one expert believes this will drive investment in new tech and markets.

ImmunoPrecise acquisition boosts antibody service

17-Aug-2017 - ImmunoPrecise Antibodies has acquired U-Protein Express, enabling it to offer microgram quantities of engineered antibodies to clients.

Comment

Modular single-use facilities rebalance Biopharma’s capacity scales

02-Aug-2017 - Modular facilities and single-use systems are fast becoming a standard part of the bioproduction infrastructure as industry looks to mitigate future capacity constraints.

Seattle Genetics gains first production site through $43m BMS plant buy

02-Aug-2017 - Seattle Genetics paid Bristol-Myers Squibb $17.8m for the biomanufacturing site and says it will spend a further $25.5m on equipment and improvements to support antibody production.

Biotest relocates Florida plasma center, ups workforce

01-Aug-2017 - Biotest Pharmaceuticals Corporation has relocated its Plasma Center in Pembroke Pines, Florida, US.

Pall: ‘More than ever, process control is a core focus area’

28-Jul-2017 - Pall Corporation has developed a control system for its single-use benchtop bioreactor and says it will continue to invest in-house for process control technologies.

Lonza envisions five new plants at Visp for modular manufacturing biz

28-Jul-2017 - Lonza has started work on a facility to house its new modular tech-based biomanufacturing service at its site in Visp, Switzerland.

Sartorius takes €10m hit on media sales due to Lonza's regulatory woes

26-Jul-2017 - Supply chain issues stemming from an FDA warning letter at a facility run by its partner Lonza have dampened Sartorius Stedim Biotech’s first half 2017 results.

Boehringer Ingelheim expands in California, adds 300 jobs

25-Jul-2017 - Boehringer Ingelheim has announced a $217m (€186m) expansion and upgrade to its manufacturing facility in Fremont, California, US.

Recreated pox virus may yield vaccines and expression systems say scientists

18-Jul-2017 - Researchers at the University of Alberta, Canada say a synthetic version of the extinct horsepox virus could yield more efficient protein expression systems and better vaccines. 

BiondVax leases site for universal flu vaccine plant in Israel

18-Jul-2017 - BiondVax Pharmaceuticals Ltd has leased space for a manufacturing plant with capacity to make tens of millions of doses of its flu vaccine, M-001.

ABEC breaks the 2,000L ‘plastic ceiling’ with 4,900L single-use bioreactor

12-Jul-2017 - ABEC says its latest offering has twice the working volume of the 2,000L bioreactor systems generally deemed to be the upper limit in single-use bioprocessing.

Shire focusing on biotechnology and R&D hubs in MA operations shake up

11-Jul-2017 - Shire will consolidate both R&D and biomanufacturing facilities in Massachusetts to establish a rare diseases hub in Cambridge and a ‘Technology Center of Excellence’ in Lexington.

Sun shines on CMO Samsung Biologics to make its psoriasis mAb candidate

04-Jul-2017 - Samsung Biologics will make Sun Pharma’s psoriasis monoclonal antibody candidate Tildrakizumab in a deal worth $55.5m.

Dispatches from BioPharma Expo, Japan

Lonza expands in Asia: 8,000L single-use in Singapore, regenerative meds in Japan

30-Jun-2017 - Lonza will install four 2,000L single-use bioreactors at its Singapore facility to cater for growing demand for small to mid-volume biologics production.

Takeda prepping to take over EU production of stem cell therapy from 2021

23-Jun-2017 - Takeda says it is assessing manufacturing options ahead of potential European approval later this year of the Crohn’s disease stem cell therapy licensed from TiGenix.

TxCell hires Lentigen to make vectors used to produce its organ rejection cell therapy

20-Jun-2017 - TxCell SA has hired Lentigen Technology Inc. to make the vectors it uses to make its T-cell transplant rejection therapy.

Single-use in Ireland on the up? GE Healthcare, Thermo Fisher and NIBRT discuss the trend

20-Jun-2017 - Ireland’s “thriving biopharma industry ” has traditionally employed large-scale bioreactors, however a new wave of biologics with changing production requirements is changing the trend, say industry representatives.

Thermo Fisher opens single-use tech testing centre in UK

14-Jun-2017 - Thermo Fisher has opened a UK test centre to allow biopharmaceutical industry customers to test single-use production technologies.

GE Healthcare training facility opens in Ireland’s ‘thriving biopharma’ market

09-Jun-2017 - The National Institute for Bioprocessing Research and Training (NIBRT) has teamed up with GE Healthcare and opened a single-use focused training facility in Dublin, Ireland. 

Securing single-use systems: SSB opts for blockbuster resins and supplier partnerships

06-Jun-2017 - Single-use vendors must address their own supply chains to help overcome end-user challenges, says Sartorius.

Horizon and ATUM combine tech to offer stable cell line production

02-Jun-2017 - Horizon Discovery will add vector and transposase technology to its gene editing services through a cross-licensing partnership with gene and protein expression services firm ATUM.

Merck & Co. €280m spend in latest commitment to Irish biomanufacturing

31-May-2017 - Global demand for its biologics and vaccines has driven expansion plans and 300 jobs across two Irish facilities says MSD.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...